Strata Skin Sciences Operating Income 2012-2025 | SSKN
Strata Skin Sciences operating income from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Strata Skin Sciences Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-9 |
| 2023 | $-9 |
| 2022 | $-5 |
| 2021 | $-4 |
| 2020 | $-4 |
| 2019 | $-3 |
| 2018 | $-3 |
| 2017 | $-2 |
| 2016 | $-4 |
| 2015 | $-16 |
| 2014 | $-17 |
| 2013 | $-24 |
| 2012 | $-23 |
| 2011 | $-20 |
|
Strata Skin Sciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-1 |
| 2025-06-30 | $-2 |
| 2025-03-31 | $-2 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $0 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-3 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $0 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $0 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-2 |
| 2020-12-31 | $0 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $0 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $0 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-9 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-4 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-5 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-6 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-5 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-5 |
| 2011-09-30 | $-6 |
| 2011-06-30 | $-5 |
| 2011-03-31 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.008B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.549B | 41.11 |
| Tempus AI (TEM) | United States | $11.881B | 0.00 |
| Doximity (DOCS) | United States | $7.738B | 31.86 |
| Hims & Hers Health (HIMS) | United States | $6.936B | 56.43 |
| IRHYTHM HLDGS (IRTC) | United States | $5.335B | 0.00 |
| Hinge Health (HNGE) | United States | $3.276B | 0.00 |
| Heartflow (HTFL) | United States | $2.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.855B | 178.54 |
| 10x Genomics (TXG) | United States | $2.791B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.744B | 45.41 |
| Omnicell (OMCL) | United States | $2.202B | 45.01 |
| Azenta (AZTA) | United States | $1.818B | 74.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.321B | 6.93 |
| Schrodinger (SDGR) | United States | $1.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.043B | 0.00 |
| Phreesia (PHR) | United States | $0.948B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.856B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.471B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.353B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 13.86 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.290B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.156B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.092B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.064B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.039B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |